Successful persistent strabismic amblyopia treatment using active therapy as an adjuvant to occlusion

采用主动疗法辅助遮盖疗法成功治疗持续性斜视性弱视。

阅读:1

Abstract

PURPOSE: A novel protocol to improve long-term results in the treatment of amblyopia was proposed. The protocol combines active home-based therapy through perceptual learning activities (Gabor patch, dichoptic stimulation, and random dot stereograms) with conventional visual therapy in the clinic as an adjunct to patching occlusion in subjects with patch-resistant amblyopia METHODS: Between 2018 and 2022, a group of patients received treatment for persistent strabismic and combined-mechanism amblyopia according to the novel treatment protocol, consisting of in-clinic orthoptics/visual therapy combined with the use of gamified PL software at home, as an adjunct to occlusion treatment. RESULTS: A retrospective analysis of treatment outcomes was subsequently carried out for 53 patients aged 7.75±5.88. Eccentric fixation was present in 17 of the 53 subjects. The distribution of patients presenting with combined-mechanism and strabismic amblyopia was 37 and 16, respectively. Eighteen patients (34 %) demonstrated measurable stereoacuity prior to treatment. Following treatment using the combined treatment protocol, forty-six (87 %) participants achieved a of logMAR 0.1 or better, mean BCVA was significantly improved, from logMAR 0.30±0.23 to logMAR 0.07±0.12 (p < 0.01). Eleven subjects (65 %) of seventeen participants with eccentric fixation achieved central fixation. In addition, stereoacuity was measurable in 43 patients (81 %). Mean stereoacuity improved, from 1200.00±258.69 arc seconds to 539.62±518.69 arc seconds (p < 0.01). These results remained stable six months after completion of the therapy. CONCLUSION: The outcomes of the proposed novel treatment protocol were reduced angle of deviation, and improved BCVA and stereoacuity in patients with persistent strabismic and combined-mechanism amblyopia.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。